Le Lézard

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the U.S ...